Announcements

The Duke Human Vaccine Institute (DHVI) Accessioning Unit and Biorepository (AUB) became an American Association of Laboratory Accreditation (A2LA) accredited biobank under the International Organization of Standardization (ISO) 20387:2018 standard in January 2024. DHVI’s AUB became one of only ten A2LA ISO 20387 accredited biobanks in the world.

This spring, 18 faculty members in the Duke University School of Medicine have been awarded distinguished professorships. The new distinguished professors will be honored at the annual distinguished professorship event on May 23, 2024.   

In total, 32 new distinguished professors across Duke University were approved by the Board of Trustees in February. 

Distinguished professorships are awarded to faculty who have demonstrated extraordinary scholarship in advancing science and improving human health.   

We are pleased to announce that Jillian Hurst, PhD, assistant professor in Pediatrics, is joining the Duke Human Vaccine Institute (DHVI) as an affiliate faculty member, effective March 17, 2024.

The Duke Human Vaccine Institute (DHVI) is pleased to announce that Rebecca Bacon, DVM, DACP, is joining DHVI as an affiliate faculty member, effective February 1, 2024.

The Duke Human Vaccine Institute (DHVI) is pleased to announce that Matthew Kelly, MD, MPH, has joined DHVI as an affiliate faculty member.

On Thursday, November 9, 2023, Kevin Saunders, PhD, was honored with the 2023 Emerging Leader Award from the Duke Medical Alumni Association during a special dinner during Medical Alumni Weekend.

Six individuals and one team were honored with Distinguished Awards from the Duke Medical Alumni Association. The special dinner celebration took place at the Washington Duke Inn.

The Duke Human Vaccine Institute (DHVI) successfully recompeted for a five-year, indefinite delivery/indefinite quantity (IDIQ) contract from the Centers for Disease Control and Prevention (CDC) Immunization Safety Office to serve as one of eight medical research centers for the Clinical Immunization Safety Assessment Project (CISA). The contract will allow DHVI to provide services thr

The Duke Human Vaccine Institute (DHVI) is pleased to announce the appointment of Herman Staats,PhD, as co-director of the Regional Biocontainment Laboratory (RBL), effective September 1, ahead of becoming the sole director of the RBL, effective January 1, 2024.

The Duke Human Vaccine Institute (DHVI) is pleased to announce that Susanna Naggie, MD, MHS, has joined DHVI as an affiliate faculty member.

Congratulations to Dr.